Literature DB >> 25662614

RIPK1 and RIPK3: critical regulators of inflammation and cell death.

Kim Newton1.   

Abstract

RIPK1 and RIPK3 (receptor-interacting serine/threonine protein kinases 1/3) interact by virtue of their RIP homotypic interaction motifs to mediate a form of cell death called necroptosis, although mice lacking these kinases have very different phenotypes. RIPK1-deficient mice die soon after birth, whereas RIPK3-deficient mice are healthy. Necroptosis involves cell rupture and is triggered by tumor necrosis factor (TNF), Toll-like receptors (TLRs), or the T cell receptor (TCR) when pro-apoptotic caspase-8 is inhibited. Various mouse models of disease are ameliorated by RIPK3 deficiency, suggesting that necroptosis contributes to pathology. Genetic rescue experiments now reveal why RIPK3-deficient are viable but RIPK1-deficient mice are not. These and other experiments indicate unexpected complexity in the regulation of both apoptosis and necroptosis by RIPK1 and RIPK3.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  RIPK1; RIPK3; apoptosis; necroptosis

Mesh:

Substances:

Year:  2015        PMID: 25662614     DOI: 10.1016/j.tcb.2015.01.001

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  103 in total

1.  Expression of receptor interacting protein 1 and receptor interacting protein 3 oval cells in a rat model of hepatocarcinogenesis.

Authors:  Marta Wójcik; Ryszard Bobowiec; Urszula Lisiecka; Anna Śmiech
Journal:  Exp Ther Med       Date:  2018-03-22       Impact factor: 2.447

2.  The NuRD chromatin-remodeling complex enzyme CHD4 prevents hypoxia-induced endothelial Ripk3 transcription and murine embryonic vascular rupture.

Authors:  Sarah Colijn; Siqi Gao; Kyle G Ingram; Matthew Menendez; Vijay Muthukumar; Robert Silasi-Mansat; Joanna J Chmielewska; Myron Hinsdale; Florea Lupu; Courtney T Griffin
Journal:  Cell Death Differ       Date:  2019-06-24       Impact factor: 15.828

3.  Neutrophil Extracellular Traps Orchestrate Necroinflammation.

Authors:  Nicolas Pallet
Journal:  J Am Soc Nephrol       Date:  2017-02-23       Impact factor: 10.121

Review 4.  Diverse ubiquitin linkages regulate RIP kinases-mediated inflammatory and cell death signaling.

Authors:  Axel Witt; Domagoj Vucic
Journal:  Cell Death Differ       Date:  2017-05-05       Impact factor: 15.828

5.  Critical role of X-box binding protein 1 in NADPH oxidase 4-triggered cardiac hypertrophy is mediated by receptor interacting protein kinase 1.

Authors:  Li Chen; Mingyue Zhao; Junli Li; Yu Wang; Qinxue Bao; Siyuan Wu; Xueqin Deng; Xiaoju Tang; Wenchao Wu; Xiaojing Liu
Journal:  Cell Cycle       Date:  2016-12-08       Impact factor: 4.534

6.  Viral RNA at Two Stages of Reovirus Infection Is Required for the Induction of Necroptosis.

Authors:  Angela K Berger; Bradley E Hiller; Deepti Thete; Anthony J Snyder; Encarnacion Perez; Jason W Upton; Pranav Danthi
Journal:  J Virol       Date:  2017-02-28       Impact factor: 5.103

Review 7.  Non-kinase targets of protein kinase inhibitors.

Authors:  Lenka Munoz
Journal:  Nat Rev Drug Discov       Date:  2017-03-10       Impact factor: 84.694

Review 8.  Lytic cell death in metabolic liver disease.

Authors:  Jérémie Gautheron; Gregory J Gores; Cecília M P Rodrigues
Journal:  J Hepatol       Date:  2020-04-13       Impact factor: 25.083

9.  NLRP3 inflammasome in NMDA-induced retinal excitotoxicity.

Authors:  Pavlina Tsoka; Paulo R Barbisan; Keiko Kataoka; Xiaohong Nancy Chen; Bo Tian; Peggy Bouzika; Joan W Miller; Eleftherios I Paschalis; Demetrios G Vavvas
Journal:  Exp Eye Res       Date:  2019-01-29       Impact factor: 3.467

10.  Knockdown of RIPK1 Markedly Exacerbates Murine Immune-Mediated Liver Injury through Massive Apoptosis of Hepatocytes, Independent of Necroptosis and Inhibition of NF-κB.

Authors:  Jo Suda; Lily Dara; Luoluo Yang; Mariam Aghajan; Yong Song; Neil Kaplowitz; Zhang-Xu Liu
Journal:  J Immunol       Date:  2016-09-07       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.